Skip to content

FDA product code · Anesthesiology

BZGSpirometer, Diagnostic

Product code BZG covers Spirometer, Diagnostic, a Class II device regulated under 21 CFR 868.1840. FDA has cleared 228 devices in this code, 1 of them in the last 12 months. Median review time across the 228 most recent decisions is 144 days. openFDA lists 1 recall record against this code.

Updated · ingest status · JSON

Class
Class II
Regulation
21 CFR 868.1840
Review panel
Anesthesiology
Clearances
228

What is happening in BZG right now?

BZG (Spirometer, Diagnostic) has two findings, most consequential first. 1 first-time filer in the last 12 months, Mesi D.O.O (K251777). The code is crowded, scoring 67 of 100 — 125 companies hold a clearance here and 1 arrived in the last 12 months (BZG:crowding).

Every factor behind the statement above, most consequential first, with the FDA records it came from.
FindingHow much it mattersFDA records
New entrantWorth knowingK251777
CrowdingContextBZG:crowding

Sources checked: predicate ancestry, recalls, adverse events, new entrants, review time, crowding. Composed . Every finding carries the record ids it was derived from; nothing here is an estimate.

How many devices has FDA cleared in BZG?

FDA has cleared 228 devices under product code BZG since the 510(k) programme began in 1976, 1 of them in the last 12 months.

Source: openFDA device/510k · retrieved

Most recent 510(k) clearances in BZG, newest first.
510(k)DeviceApplicantDecision
K251777MESI mTABLET SPIROMesi D.O.O.
K241843TD-7301 Spirometer (TD-7301)Gostar Co., Ltd.
K231416Air Next (NVD-02)Nuvoair AB
K230501Spirobank OxiMir Medical International Research USA
K230178EasyOne Sky SpirometerNdd Medizintechnik AG
K222525Alveoair Digital SpirometerRoundworks Technologies Private Limited
K222443Air Smart Extra SpirometerFeellife Health, Inc.
K213754SpiroHome Personal, SpiroHome ClinicInofab Saglik Teknolojileri A.S
K213872ComPAS2Morgan Scientific, Inc.
K212938Vitalograph Model 6000 AlphaVitalograph Ireland, Ltd.

How long does FDA review take for BZG?

The median FDA review time for BZG is 144 days, measured across the 228 most recent decisions with both a received date and a decision date.

Review time here is decision date minus date received, as published by FDA. It is elapsed calendar time, not FDA review days — the two differ whenever the agency stops the clock for an additional information request.

Source: openFDA device/510k · retrieved

Are there recalls in BZG?

openFDA lists 1 recall record against product code BZG. A recall record covers one firm's corrective action and may span many device lots.

  • Z-0324-2025Open, ClassifiedBaxter Healthcare Corporation

    There is the potential for exam files being assigned duplicate Unique Identifiers (UIDs),. If the system receiving the DICOM file (e.g., Picture Archiving and Communication System (PACS)) relies solely on the UID to accept exams, this could lead to a mismatch of the patients identification with their physiological data.

Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Status is FDA's own wording; a terminated recall is a closed one, and the total spans the code's whole history, not just what is open today.

Source: openFDA device/recall · retrieved

How many adverse events are reported for BZG?

MAUDE holds 6 adverse-event reports naming product code BZG.

MAUDE reports are submitted by manufacturers, importers, user facilities and the public. They are unverified, and a report is not proof that the device caused the event.

Source: openFDA device/event · retrieved

Is adverse-event reporting in BZG unusual?

BZG does not yet have twelve months of adverse-event history in our data, so there is no expected range to compare against. That is a gap in what we hold, not a statement about the device.

Monthly adverse-event reports naming BZG, against the expected range computed from this code's own history. Shaded band is the expected range; a bar above it is the month flagged. Retrieved 11 August 2026.
Reports received per month for BZG, with the expected range and whether the month fell outside it.
MonthReportsExpectedVerdict
1Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history

6 months do not have a full, unbroken year of history before them, so no expected range is shown for those. Insufficient history is reported as insufficient rather than as zero: an empty baseline would turn a gap in our data into a spike.

Who has entered BZG in the last year?

One company filed in BZG for the first time in the last 12 months.

First-time filers in BZG within the last 12 months, with the clearance that marks their entry.
CompanyFirst clearedK-number
Mesi D.O.O.K251777

"First time" means their first clearance in this product code, not their first ever — an established manufacturer entering a new category is exactly the movement worth knowing about.

Source: openFDA device/510k · retrieved

What are the predicate devices in BZG?

FDA publishes no machine-readable predicate field, so no predicate chain is recorded for this code yet.

A predicate chain matters because a device inherits the safety history of what it was compared to. FDA publishes the chain only inside each 510(k) summary PDF, never as data — so where we have edges, they are read from those documents, and where we do not, we say so instead of showing an empty list.

Who files 510(k)s in BZG?

Across the 228 most recent decisions, these applicants filed most often in BZG.

Most frequent applicants in BZG among recent decisions.
ApplicantRecent clearances
Mir Medical Intl. Research Srl9
Sdi Diagnostics, Inc.8
Vitalograph (Ireland) , Ltd.6
Future Impex Corp.5
Medical Equipment Designs, Inc.5

Applicant names above are exactly as FDA published them, so one company can appear under several spellings.

The same makers, after name resolution

2 companies in BZG file under more than one spelling. Resolving them to one identity — across all six datasets, not just this one — is what makes a joined count possible at all.

Companies in BZG whose FDA filings use more than one spelling of the same name.
CompanyClearancesFDA spellings merged
Vitalograph (Ireland) , Ltd.92
Vitalograph , Ltd.72

Merges are measured against a hand-labelled sample and held above 98% precision; pairs the matcher is unsure of are queued for a person rather than merged. See DeviceSignal.

Source: openFDA device/510k · retrieved

Watch BZG

Get an email the morning anything changes in BZG — a new clearance, a recall, or an adverse-event spike above this code's own baseline.

Start watching BZG

Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.